Efek Samping Kortikosteroid Jangka Panjang pada Anak dengan Sindrom Nefrotik

Authors

  • Jefferson G. Halim Universitas Sam Ratulangi
  • Adrian Umboh Universitas Sam Ratulangi
  • Praevilia M. Salendu Universitas Sam Ratulangi

DOI:

https://doi.org/10.35790/msj.v8i1.62804

Keywords:

sindrom nefrotik; anak; efek samping kortikosteroid jangka panjang

Abstract

Abstract: Nephrotic syndrome is one of the kidney diseases in children with the majority of patients experiencing disease recurrence. First-line therapy for nephrotic syndrome is oral corticosteroids, which reduce mortality and induce remission in approximately 80%. Side effects of long-term corticosteroid therapy in children with nephrotic syndrome include moon face, impaired growth, hypertension, and substantial weight gain. This study aimed to describe the side effects due to long-term use of corticosteroids in children with nephrotic syndrome treated at Prof. Dr. R. D. Kandou Hospital. This was a descriptive study with a cross-sectional design. This study involved 156 nephrotic syndrome patients, of whom 30 fulfilled the inclusion criteria, while 126 were excluded. The results showed that the majority of patients were male, aged 10-18 years. The side effects of corticosteroid in nephrotic syndrome patients were moon face (76.7%), short stature (36,67%), underweight (50%), hypertension (13,33%), and obesity (3,33%). In conclusion, the most common side effects that occur due to long-term consumption of corticosteroids are moon face, growth disorders, hypertension, and obesity. These findings encourage clinicians to observe and prevent the side effects of long-term corticosteroid use.

Keywords: nephrotic syndrome; children; side effects of long-term corticosteroids

 

Abstrak: Sindrom nefrotik ialah salah satu penyakit ginjal pada anak dengan kecenderungan mengalami kekambuhan penyakit. Terapi lini pertama untuk sindrom nefrotik ialah kortikosteroid oral, yang mengurangi angka kematian dan menginduksi remisi sekitar 80%. Efek samping terapi kortikosteroid jangka panjang pada anak dengan sindrom nefrotik antara lain moon face, gangguan pertumbuhan, hipertensi, dan penambahan berat badan yang bermakna. Penelitian ini bertujuan untuk mendeskripsikan efek samping akibat konsumsi kortikosteroid jangka panjang pada anak sindrom nefrotik yang dirawat di RSUP Prof. Dr. R. D. Kandou. Jenis penelitian ialah deskriptif dengan desain potong lintang. Penelitian ini melibatkan 156 pasien sindrom nefrotik; 30 diantaranya memenuhi kriteria inklusi, sedangkan 126 lainnya dieksklusi. Hasil penelitian mendapatkan mayoritas pasien ialah laki-laki, berusia 10-18 tahun. Sebanyak 76,67% penderita sindrom nefrotik memiliki moon face, 36,67% dengan perawakan pendek, 50% dengan berat badan kurang, 13,33% dengan hipertensi, dan 3,33% dengan obesitas. Simpulan penelitian ini ialah efek samping yang paling sering terjadi akibat konsumsi kortikosteroid jangka panjang ialah moon face, gangguan pertumbuhan, hipertensi dan obesitas. Temuan ini mendorong klinisi untuk tetap melakukan observasi dan pencegahan terhadap efek samping penggunaan kortikosteroid jangka panjang.

Kata kunci: sindrom nefrotik; anak; efek samping kortikosteroid jangka panjang

Author Biographies

Jefferson G. Halim, Universitas Sam Ratulangi

Program Studi Pendidikan Dokter Fakultas Kedokteran Universitas Sam Ratulangi, Manado, Indonesia

Adrian Umboh, Universitas Sam Ratulangi

Bagian Ilmu Kesehatan Anak Fakultas Kedokteran Universitas Sam Ratulangi, Manado, Indonesia

Praevilia M. Salendu, Universitas Sam Ratulangi

Bagian Ilmu Kesehatan Anak Fakultas Kedokteran Universitas Sam Ratulangi, Manado, Indonesia

References

1. Rachmadi D, Sekarwana N, Hilmanto D, Garna H. Buku Ajar Nefrologi Anak (3rd ed). Jakarta Pusat: Badan Penerbit IDAI; 2017. p. 31–53.

2. Nilawati G. Profil sindrom nefrotik pada ruang perawatan anak RSUP Sanglah Denpasar. Sari Pediatri. 2016;14(4):269. Available from: https://saripediatri.org/index.php/sari-pediatri/article/view/355

3. Downie ML, Gallibois C, Parekh RS, Noone DG. Nephrotic syndrome in infants and children: pathophysiology and management. Paediatrics International Child Health. 2017;37(4):248–58. Available from: https://www.tandfonline.com/doi/full/10.1080/20469047.2017.1374003

4. Nurhasnah N, Elvina R, Lestari D. Hubungan penggunaan kortikosteroid dengan kejadian infeksi pada pasien sindrom nefrotik di rumah sakit ‘X’ Jakarta. Media Farmasi. 2018;15(2):122. Available from: http://journal.uad.ac.id/index.php/Media-Farmasi/article/view/12664

5. Wigati R, Laksmi E. Alternatif Terapi inisial sindrom nefrotik untuk menurunkan kejadian relaps. Sari Pediatri. 2016;11(6):415. Available from: https://saripediatri.org/index.php/sari-pediatri/article/view/554

6. Ramdhani SS, Harun N, Marlina T. Evaluation of the rationality of appropriate doses of corticosteroid drugs in patients with nephrotic syndrome in hospitals. Jurnal Kesehatan STIKes Muhammadiyah Ciamis. 2022;9(2):7–16. Available from: https://ojs.stikesmucis.ac.id/index.php/jurkes/article/view/342

7. Asyik H, Putra Gunawan E, Zahira A, Sinta P, Purwoko M, Ilmu D, et al. Pemberian terapi kortikosteroid oral memengaruhi tinggi badan penderita sindrom nefrotik di RSUD Palembang Bari. Medical Scientific Journal. 2021;2(1):22–7. Available from: https://jurnal.um-palembang.ac.id/MSJ/article/view/2619

8. Albar H, Bilondatu F. Profile of pediatric nephrotic syndrome in Wahidin Sudirohusodo Hospital, Makassar, Indonesia. Cermin Dunia Kedokteran. 2019;46(3):185–8. Available from: https://cdkjournal.com/index. php/cdk/article/view/494

9. Croitoru A, Balgradean M. Treatment-Associated Side Effects in patients with steroid-dependent nephrotic syndrome. Maedica (Bucur). 2022;17(2):285–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/36032609

10. Al-Jabr KH, Alhumaidan LS, Alghamdi AA, Almutairi MSL, Alsubaihi AA, Alrasheedi SM, et al. Awareness of side effects of corticosteroids among users and nonusers in Saudi Arabia. Journal of Pharmacy and Bioallied Science. 202416(Suppl2):S1612–8. Available from: https://journals.lww.com/10.4103/jpbs.jpbs_925_23

11. Whalen MJ, Pak JS, Lascano D, Ahlborn D, Matulay JT, McKiernan JM, et al. Oncologic outcomes of definitive treatments for low- and intermediate-risk prostate cancer after a period of active surveillance. Clin Genitourin Cancer]. 2018;16(2):e425–35. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1558767317303130

12. Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol. 2001;33(4):289–94. Available from: http://journals.lww.com/00004836-200110000-00006

13. Pardede SO. Tata laksana non imunosupresan sindrom nefrotik pada anak. Sari Pediatri. 2017;19(1):53. Available from: https://saripediatri.org/index.php/sari-pediatri/article/view/1133

14. Raisania I, Muryawan MH, Radityo S AN. Hubungan antara terapi kortikosteroid dengan kejadian hipertensi pada anak dengan sindrom nefrotik. Jurnal Kedokteran Diponegoro. 2012;1(1). Available from: https://media.neliti.com/media/publications/112129-ID-hubungan-antara-terapi-kortikosteroid-de.pdf

Downloads

Published

2025-09-02

How to Cite

Halim, J. G., Umboh, A., & Salendu, P. M. (2025). Efek Samping Kortikosteroid Jangka Panjang pada Anak dengan Sindrom Nefrotik . Medical Scope Journal, 8(1), 141–145. https://doi.org/10.35790/msj.v8i1.62804